CollPlant(CLGN) - 2023 Q1 - Quarterly Report

Exhibit 99.1 Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update ● Continued advancement of strategic collaboration with AbbVie to develop dermal and soft tissue filler products using CollPlant's recombinant human (rh)Collagen ● Additional large-animal study planned in H2 2023 to further 3D bioprinted regenerative breast implant program ● Conference call to be held on March 29, 2023 at 10:00 am U.S. ET; Dial-in information herein Rehovot, Israel, March 29, ...